Watch the Replay: The Smallcap Revival Summits
Here is the latest financial fact sheet of Crisil. For more details, see the Crisil quarterly results and Crisil share price and chart.
% ch | % | -0.1 |
No. of shares | m | 72.30 |
% ch week | % | -1.3 |
% ch 1-mth | % | -0.2 |
% ch 12-mth | % | 6.4 |
52 week H/L | Rs | 2,125.0/1,083.5 |
No. of Mths Year Ending |
12 Dec-15* |
12 Dec-16* |
12 Dec-17* |
12 Dec-18* |
12 Dec-19* |
5-Yr Chart Click to enlarge
|
---|
CRISIL EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 1,995 | 2,490 | 2,285 | 2,021 | 2,070 | |
Low | Rs | 1,852 | 1,750 | 1,753 | 1,650 | 1,136 | |
Sales per share (Unadj.) | Rs | 193.8 | 216.9 | 231.3 | 242.4 | 239.5 | |
Earnings per share (Unadj.) | Rs | 40.0 | 41.3 | 42.5 | 50.3 | 47.6 | |
Diluted earnings per share | Rs | 39.4 | 40.7 | 42.1 | 50.2 | 47.6 | |
Cash flow per share (Unadj.) | Rs | 45.3 | 48.9 | 49.0 | 56.3 | 52.7 | |
Dividends per share (Unadj.) | Rs | 23.00 | 27.00 | 28.00 | 30.00 | 32.00 | |
Adj. dividends per share | Rs | 22.65 | 26.64 | 27.77 | 29.93 | 32.00 | |
Dividend yield (eoy) | % | 1.2 | 1.3 | 1.4 | 1.6 | 2.0 | |
Book value per share (Unadj.) | Rs | 135.6 | 138.1 | 146.2 | 157.5 | 162.1 | |
Adj. book value per share | Rs | 133.6 | 136.3 | 145.0 | 157.2 | 162.1 | |
Shares outstanding (eoy) | m | 71.20 | 71.34 | 71.70 | 72.12 | 72.30 | |
Bonus/Rights/Conversions | - | ESOS | ESOS | ESOS | ESOS | ||
Price / Sales ratio | x | 9.9 | 9.8 | 8.7 | 7.6 | 6.7 | |
Avg P/E ratio | x | 48.0 | 51.4 | 47.5 | 36.5 | 33.7 | |
P/CF ratio (eoy) | x | 42.5 | 43.4 | 41.2 | 32.6 | 30.4 | |
Price / Book Value ratio | x | 14.2 | 15.3 | 13.8 | 11.6 | 9.9 | |
Dividend payout | % | 57.4 | 65.4 | 65.9 | 59.6 | 67.3 | |
Avg Mkt Cap | Rs m | 136,925 | 151,241 | 144,744 | 132,362 | 115,879 | |
No. of employees | `000 | NA | NA | 4.7 | 3.8 | 3.6 | |
Total wages/salary | Rs m | 6,939 | 7,877 | 8,459 | 8,874 | 8,776 | |
Avg. sales/employee | Rs Th | NM | NM | 3,501.1 | 4,606.1 | 4,798.3 | |
Avg. wages/employee | Rs Th | NM | NM | 1,785.8 | 2,337.6 | 2,431.6 | |
Avg. net profit/employee | Rs Th | NM | NM | 642.7 | 956.5 | 953.0 |
CRISIL INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 13,799 | 15,475 | 16,585 | 17,485 | 17,317 | |
Other income | Rs m | 432 | 497 | 254 | 734 | 728 | |
Total revenues | Rs m | 14,232 | 15,972 | 16,838 | 18,219 | 18,046 | |
Gross profit | Rs m | 3,996 | 4,433 | 4,553 | 4,712 | 4,558 | |
Depreciation | Rs m | 371 | 545 | 466 | 428 | 369 | |
Interest | Rs m | 0 | 0 | 4 | 22 | 2 | |
Profit before tax | Rs m | 4,057 | 4,385 | 4,336 | 4,996 | 4,916 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 1,206 | 1,442 | 1,292 | 1,365 | 1,476 | |
Profit after tax | Rs m | 2,852 | 2,943 | 3,044 | 3,631 | 3,440 | |
Gross profit margin | % | 29.0 | 28.6 | 27.5 | 27.0 | 26.3 | |
Effective tax rate | % | 29.7 | 32.9 | 29.8 | 27.3 | 30.0 | |
Net profit margin | % | 20.7 | 19.0 | 18.4 | 20.8 | 19.9 |
CRISIL BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 8,279 | 9,606 | 7,068 | 8,249 | 9,650 | |
Current liabilities | Rs m | 4,427 | 3,852 | 4,287 | 4,759 | 4,938 | |
Net working cap to sales | % | 27.9 | 37.2 | 16.8 | 20.0 | 27.2 | |
Current ratio | x | 1.9 | 2.5 | 1.6 | 1.7 | 2.0 | |
Inventory Days | Days | 0 | 0 | 0 | 0 | 0 | |
Debtors Days | Days | 51 | 49 | 57 | 59 | 42 | |
Net fixed assets | Rs m | 1,001 | 827 | 746 | 801 | 721 | |
Share capital | Rs m | 71 | 71 | 72 | 72 | 72 | |
"Free" reserves | Rs m | 9,586 | 9,782 | 10,414 | 11,290 | 11,647 | |
Net worth | Rs m | 9,657 | 9,854 | 10,486 | 11,363 | 11,719 | |
Long term debt | Rs m | 0 | 0 | 0 | 1 | 0 | |
Total assets | Rs m | 13,367 | 13,852 | 14,947 | 16,338 | 16,887 | |
Interest coverage | x | NM | NM | 1,058.6 | 225.0 | 2,138.3 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 1.0 | 1.1 | 1.1 | 1.1 | 1.0 | |
Return on assets | % | 21.3 | 21.2 | 20.4 | 22.4 | 20.4 | |
Return on equity | % | 29.5 | 29.9 | 29.0 | 32.0 | 29.3 | |
Return on capital | % | 42.0 | 44.5 | 41.4 | 44.2 | 42.0 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 5,611 | 7,120 | 0 | 0 | 0 | |
Fx outflow | Rs m | 1,958 | 2,341 | 0 | 0 | 0 | |
Net fx | Rs m | 3,653 | 4,778 | 0 | 0 | 0 |
CRISIL CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 2,704 | 2,790 | 2,907 | 3,785 | 4,459 | |
From Investments | Rs m | 9 | -247 | -1,767 | -718 | -710 | |
From Financial Activity | Rs m | -2,617 | -2,269 | -1,866 | -2,032 | -2,289 | |
Net Cashflow | Rs m | 95 | 330 | -752 | 1,108 | 1,396 |
Share Holding
|
Company Information
|
CHM: Douglas Peterson | COMP SEC: Neelabja Chakrabarty | YEAR OF INC: 1987 | BSE CODE: 500092 | FV (Rs): 1 | DIV YIELD (%): 1.7 |
Read: CRISIL 2018-19 Annual Report Analysis
More Rating Agencies Company Fact Sheets: ICRA CARE RATING
Compare CRISIL With: ICRA CARE RATING
Extending losses to the fifth straight session, Indian share markets witnessed selling pressure throughout the day today and ended deep in the red.
Here's an analysis of the annual report of CRISIL for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of CRISIL. Also includes updates on the valuation of CRISIL.
For the quarter ended March 2020, CRISIL has posted a net profit of Rs 881 m (up 15.0% YoY). Sales on the other hand came in at Rs 4 bn (up 2.9% YoY). Read on for a complete analysis of CRISIL's quarterly results.
For the quarter ended December 2019, CRISIL has posted a net profit of Rs 953 m (down 16.2% YoY). Sales on the other hand came in at Rs 5 bn (down 0.6% YoY). Read on for a complete analysis of CRISIL's quarterly results.
Here's an analysis of the annual report of CRISIL for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of CRISIL. Also includes updates on the valuation of CRISIL.
More Views on NewsIn this video, I'll show you why it might be the right time to take money of the table in pharma stocks.
The pandemic failed to thwart Richa's investing success formula for 2020.
In this video, I'll show you a crucial chart that you need to check before you decide to sell any stock or index.
Our ace stock picker is ready to capitalise on a big growth opportunity.
More